查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年多重检测市场预测：按产品类型、技术、应用、最终用户和地区进行的全球分析
市场调查报告书
商品编码
1383379

2030 年多重检测市场预测：按产品类型、技术、应用、最终用户和地区进行的全球分析

Multiplex Assays Market Forecasts to 2030 - Global Analysis By Product, Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球多重检测市场规模将达到 38 亿美元，预计到 2030 年将达到 79 亿美元，预测期内CAGR为 10.8%。

多重测定是一种实验室技术，可同时测量一个生物样本中的多种分析物，例如蛋白质、核酸或其他分子。这种实验室技术广泛应用于生物学、医学和诊断的许多领域，使研究人员能够从单一样本中提取更多资讯。多重检测技术经常用于医院、临床实验室、研究机构、製药公司和生物技术公司。

根据世界卫生组织2023年7月发布的报告，估计每年新增感染者3.74亿，四分之一的人可以治愈，15岁至49岁的超过5亿人感染单纯疱疹病毒。您患有生殖器感染（单纯疱疹病毒或疱疹）。

多重检测技术的进展

PCR 和免疫测量等多重分析彻底改变了研究和诊断。这些创新方法透过识别一个样品中的多种分析物来节省时间和金钱。免疫测量使用抗体来识别和定量目标分析物。多重免疫测量可评估单一样本中的多种生物标记、细胞激素或分析物。这可以让您节省时间和金钱，同时增加对疾病的了解。萤光的引子和探针可以在一次反应中扩增和检测多个目标序列，从而实现多种分析物的高通量筛选。

高成本

多重检测设备的初始投资较高。儘管有长期的节省和效益，但初始投资成本可能会在一定程度上抑制多重检测的小规模使用。所需试剂的变动成本及其供应商固定的成本增加了总支出。此外，维护和保险、实验室监督和管理费用（包括公用事业、空间和管理）都是额外成本。因此，高设备成本是限制多重侦测广泛普及的主要因素。

製药和生物技术产业的扩张

多重检测市场的成长主要受到製药和生物技术产业扩张的推动。先进的诊断工具在支持这些行业的研究、药物开发和临床应用方面发挥着至关重要的作用。此外，多重检测对于这两个领域都是必不可少的，因为它们允许在一个样本中同时分析多个生物标记。由于这些特征，多重检测在各种生物技术和製药应用中变得越来越重要。

资料安全问题

资料安全问题为多重检测市场带来了重大风险。多重检测中资料的资料的敏感度增加了诈欺的存取、洩漏和滥用的风险。医疗和研究领域有严格的资料保护条例，需要强而有力的网路安全措施。研究和资料的潜在洩漏资料市场接受度并损害相关人员的信任。因此，市场的成长受到阻碍。

COVID-19 的影响

市场受到了 COVID-19 的重大积极影响。在此大流行期间，使用了 SARS-CoV-2 等多重检测方法来诊断新冠病毒。疫情期间，随着世界各地的卫生系统争先恐后地扩大检测能力和提高效率，对多重检测的需求激增。 FDA已向多家公司授予批准，进一步为市场拓展铺路。在大流行期间，多重检测製造商推出了许多检测方法，提高了市场成长率。

流式细胞仪领域预计将在预测期内成为最大的领域

流式细胞仪领域估计占据最大份额。流式细胞仪在速度、灵敏度和准确性方面具有显着优势，允许在单细胞层级同时分析多个参数。流式细胞仪领域由于其能够产生大量资料并提供高通量分析而成为市场领先的技术。随着对个人化医疗和精准疾病诊断的需求不断增加，客户越来越多地选择流式细胞仪等能够提供全面、可靠结果的仪器。预计未来几年，多重检测市场将以流式细胞仪领域最快的速度成长。

预计研发领域在预测期内CAGR最高

多重检测经常用于研究环境中，以阐明复杂的生物过程、疾病机制、药物开发等。研发部门引领市场，因为他们可以为科学研究和医药创新提供关键资料。复杂疾病数量的不断增加以及对尖端治疗解决方案的需求正在推动对产生新治疗方法的研发计划的投资增加。研究和开发领域预计将在多重检测市场中成长最快。

比最大的地区

由于多重检测产品和服务的高采用率以及新兴市场资本利得的显着增长，北美在预测期内获得了最大的市场占有率份额。最近推出的产品和先进的医疗保健系统也有助于该地区的市场扩张。此外，大公司的存在、研发设施、高医疗旅游和高购买力也有助于市场扩张。

复合CAGR最高的地区：

由于患有感染疾病和慢性病的人数增加、人们对使用多重检测产品和服务的好处的认识不断提高以及中国等人口大国购买力的不断提高，亚太地区将在预测期内继续增长预计在此期间将出现获利成长。此外，由于新的主要参与者进入市场、人均支出增加以及政府措施不断增加，该地区的市场正在成长。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/CAGR（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球多重检测市场：按产品

  • 介绍
  • 装置
  • 消耗品
  • 软体和服务

第6章全球多重检测市场：依类型

  • 介绍
  • 基于蛋白质的多重检测
    • 基于微珠的蛋白质检测
    • 平面蛋白质测定
    • 其他蛋白质多重检测
  • 核酸多重检测
    • 基于微珠的核酸检测
    • 平面核酸测定
    • 其他核酸多重检测
  • 基于细胞的多重检测

第7章全球多重检测市场：依技术分类

  • 介绍
  • 发光
  • 流式细胞仪
  • 多重实时 PCR
  • 萤光侦测
  • 其他技术

第8章全球多重检测市场：按应用

  • 介绍
  • 研究与开发
    • 生物标记的发现与检验
    • 药物研发发现与开发
  • 临床诊断
    • 感染疾病
    • 心血管疾病
    • 癌症
    • 自体免疫疾病
    • 代谢及内分泌疾病
    • 神经系统疾病
    • 其他临床诊断

第9章全球多重检测市场：依最终用户分类

  • 介绍
  • 医院和诊断实验室
  • 製药和生物技术公司
  • 学术机构
  • 其他最终用户

第10章全球多重检测市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 中东和非洲其他地区

第11章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第12章公司简介

  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • Danaher Corporation
  • Hoffmann-La Roche
  • Biomerieux
  • Bio-Rad Laboratories
  • Sekisui Medical
  • Buhlmann Laboratories
  • Randox Laboratories
  • Merck Sharp & Dohme Corp
  • Illumina Inc
  • Qiagen
  • Abcam plc
  • Agilent Technologies
  • Meso Scale Diagnostics LLC
Product Code: SMRC24229

According to Stratistics MRC, the Global Multiplex Assays Market is accounted for $3.8 billion in 2023 and is expected to reach $7.9 billion by 2030 growing at a CAGR of 10.8% during the forecast period. A multiplex assay is a lab technique that measures several analytes, such as proteins, nucleic acids, or other molecules, simultaneously in a single biological sample. This lab technique is widely used in many areas of biology, medicine, and diagnostics and enables researchers to extract more information from a single sample. Hospitals, clinical laboratories, research facilities, and pharmaceutical and biotechnological companies all frequently use the multiplex assay technique.

According to the report published by WHO in July 2023, each year there are an estimated 374 million new infections with 1 of 4 curable, more than 500 million people 15-49 years of age are estimated to have a genital infection with herpes simplex virus (HSV or herpes).

Market Dynamics:

Driver:

Advances in multiplex assay technologies

Multiplex assays have revolutionized research and diagnosis, such as PCR and immunoassays. These innovative methods save time and money by identifying numerous analytes in a single sample. Antibodies are used in immunoassays to identify and quantify target analytes. With multiplex immunoassays, numerous biomarkers, cytokines, or analytes are assessed in a single sample. This enhances knowledge of illness while saving time and money. Fluorescently tagged primers and probes may amplify and detect multiple target sequences in a single reaction, enabling high-throughput screening of multiple analytes.

Restraint:

High cost

The initial investment in multiplex assay equipment is high. Despite long-term savings and advantages, the initial investment costs may restrain the small-scale use of multiplex assays to a certain extent. The variable costs of the reagents needed and those fixed by the suppliers thereof add to the overall expenditure. Furthermore, maintenance and insurance, laboratory supervision, and overhead costs (including utilities, space, and administration) are also additional expenses. As a result, high instrument costs are a major factor limiting the wider adoption of multiplex assays.

Opportunity:

Expansion of the pharmaceutical and biotechnology industries

The growth of the multiplex assay market has been significantly fuelled by the expansion of the pharmaceutical and biotechnology industries. Advanced diagnostic tools play a critical role in supporting research, drug development, and clinical applications in these industries. Moreover, because multiplex assays allow for the simultaneous analysis of multiple biomarkers in a single sample, they are essential to both fields. Multiplex assays are becoming more and more essential in a variety of biotechnology and pharmaceutical applications due to this capability.

Threat:

Data security concerns

Data security concerns pose significant risks to the multiplex assay market. The risk of unauthorised access, breaches, or misuse is elevated due to the sensitive nature of the clinical and biological data used in multiplex assessments. Stringent data protection regulations in the healthcare and research sectors require robust cyber security measures. The potential harm to research and patient data hinders market acceptance and erodes confidence among stakeholders. Thus, market growth is hampered.

COVID-19 Impact

The market has been greatly and positively impacted by COVID-19. Multiplex assays, such as the SARS-CoV-2 assay, were used to diagnose COVID during this pandemic phase. During the pandemic, the demand for multiplex assays skyrocketed as healthcare systems worldwide scrambled to expand testing capabilities and improve efficiency. The FDA has granted approval to a number of companies, which has further paved the way for the market's expansion. During the pandemic, multiplex assay manufacturers have introduced a number of assays, which has increased the market's growth rate.

The flow cytometry segment is expected to be the largest during the forecast period

The flow cytometry segment is estimated to hold the largest share. Flow cytometry provides major advantages in terms of speed, sensitivity, and accuracy and allows for the simultaneous analysis of multiple parameters at the single-cell level. The flow cytometry segment is a leading technology in the market because of its capacity to generate large amounts of data and offer high-throughput analysis. Customers are more likely to choose devices like flow cytometry that can deliver thorough and dependable results due to the rising demand for personalized medicine and precise disease diagnosis. In the upcoming years, the multiplex assay market is anticipated to grow at the fastest rate in the flow cytometry segment.

The research & development segment is expected to have the highest CAGR during the forecast period

The research & development segment is anticipated to have lucrative growth during the forecast period Multiplex assays are frequently used in research settings to shed light on intricate biological processes, illness mechanisms, and medication development. The research and development sector is a market leader because it can supply important data for scientific investigations and pharmaceutical innovations. Customers are increasingly willing to invest in research and development projects that can result in novel treatments due to the rising incidence of complex diseases and the demand for cutting-edge therapeutic solutions. In the multiplex assay market, the research and development segment is anticipated to grow at the quickest rate.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to the high rate of adoption of multiplex assay goods and services as well as the notable rise in capital income in developed nations. The region's access to recently released goods and sophisticated healthcare systems also contribute to the market's expansion. Additionally, the market is expanding due to the presence of major players, R&D facilities, high levels of medical tourism, and strong purchasing power.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, due to the rise in the number of people with infectious and chronic illnesses, the growing awareness of the benefits of using multiplex assay goods and services, and the rising purchasing power of highly populated nations like China and India. Additionally, the region's market is growing because of things like new major players entering the market, rising per capita spending, and more government initiatives to improve the region's healthcare infrastructure.

Key players in the market

Some of the key players in the Multiplex Assays Market include: Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, Danaher Corporation, Hoffmann-La Roche, Biomerieux, Bio-Rad Laboratories, Sekisui Medical, Buhlmann Laboratories, Randox Laboratories, Merck Sharp & Dohme Corp, Illumina Inc, Qiagen, Abcam plc, Agilent Technologies and Meso Scale Diagnostics LLC.

Key Developments:

In July 2023, QIAGEN announced that the expansion of its digital PCR (dPCR) offering for the development of cell and gene therapies in the biopharma industry.

In June 2023, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced that it has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A., a Warsaw, Poland, based developer of the PCR ONE technology for rapid, automated detection of infections via highly multiplexed PCR assays.

Products Covered:

  • Instruments
  • Consumables
  • Software & Services

Types Covered:

  • Protein Based Multiplex Assays
  • Nucleic Acid Multiplex Assays
  • Cell-based Multiplex Assays

Technologies Covered:

  • Luminescence
  • Flow Cytometry
  • Multiplex Real-Time PCR
  • Fluorescence Detection
  • Other Technologies

Applications Covered:

  • Research & Development
  • Clinical Diagnostics

End Users Covered:

  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Multiplex Assays Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
  • 5.3 Consumables
  • 5.4 Software & Services

6 Global Multiplex Assays Market, By Type

  • 6.1 Introduction
  • 6.2 Protein Based Multiplex Assays
    • 6.2.1 Bead-Based Protein Assays
    • 6.2.2 Planar Protein Assays
    • 6.2.3 Other Protein Multiplex Assays
  • 6.3 Nucleic Acid Multiplex Assays
    • 6.3.1 Bead-Based Nucleic Acid Assays
    • 6.3.2 Planar Nucleic Acid Assays
    • 6.3.3 Other Nucleic Acid Multiplex Assays
  • 6.4 Cell-based Multiplex Assays

7 Global Multiplex Assays Market, By Technology

  • 7.1 Introduction
  • 7.2 Luminescence
  • 7.3 Flow Cytometry
  • 7.4 Multiplex Real-Time PCR
  • 7.5 Fluorescence Detection
  • 7.6 Other Technologies

8 Global Multiplex Assays Market, By Application

  • 8.1 Introduction
  • 8.2 Research & Development
    • 8.2.1 Biomarker Discovery & Validation
    • 8.2.2 Drug Discovery & Development
  • 8.3 Clinical Diagnostics
    • 8.3.1 Infectious Diseases
    • 8.3.2 Cardiovascular Diseases
    • 8.3.3 Cancer
    • 8.3.4 Autoimmune Diseases
    • 8.3.5 Metabolism & Endocrinology Disorders
    • 8.3.6 Nervous System Disorders
    • 8.3.7 Other Clinical Diagnostics

9 Global Multiplex Assays Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Diagnostic Laboratories
  • 9.3 Pharmaceutical & Biotechnology Companies
  • 9.4 Academic Institutes
  • 9.5 Other End Users

10 Global Multiplex Assays Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Laboratories
  • 12.2 Thermo Fisher Scientific
  • 12.3 Siemens Healthineers
  • 12.4 Danaher Corporation
  • 12.5 Hoffmann-La Roche
  • 12.6 Biomerieux
  • 12.7 Bio-Rad Laboratories
  • 12.8 Sekisui Medical
  • 12.9 Buhlmann Laboratories
  • 12.10 Randox Laboratories
  • 12.11 Merck Sharp & Dohme Corp
  • 12.12 Illumina Inc
  • 12.13 Qiagen
  • 12.14 Abcam plc
  • 12.15 Agilent Technologies
  • 12.16 Meso Scale Diagnostics LLC

List of Tables

  • Table 1 Global Multiplex Assays Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Multiplex Assays Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Multiplex Assays Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 4 Global Multiplex Assays Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 5 Global Multiplex Assays Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 6 Global Multiplex Assays Market Outlook, By Type (2021-2030) ($MN)
  • Table 7 Global Multiplex Assays Market Outlook, By Protein Based Multiplex Assays (2021-2030) ($MN)
  • Table 8 Global Multiplex Assays Market Outlook, By Bead-Based Protein Assays (2021-2030) ($MN)
  • Table 9 Global Multiplex Assays Market Outlook, By Planar Protein Assays (2021-2030) ($MN)
  • Table 10 Global Multiplex Assays Market Outlook, By Other Protein Multiplex Assays (2021-2030) ($MN)
  • Table 11 Global Multiplex Assays Market Outlook, By Nucleic Acid Multiplex Assays (2021-2030) ($MN)
  • Table 12 Global Multiplex Assays Market Outlook, By Bead-Based Nucleic Acid Assays (2021-2030) ($MN)
  • Table 13 Global Multiplex Assays Market Outlook, By Planar Nucleic Acid Assays (2021-2030) ($MN)
  • Table 14 Global Multiplex Assays Market Outlook, By Other Nucleic Acid Multiplex Assays (2021-2030) ($MN)
  • Table 15 Global Multiplex Assays Market Outlook, By Cell-based Multiplex Assays (2021-2030) ($MN)
  • Table 16 Global Multiplex Assays Market Outlook, By Technology (2021-2030) ($MN)
  • Table 17 Global Multiplex Assays Market Outlook, By Luminescence (2021-2030) ($MN)
  • Table 18 Global Multiplex Assays Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 19 Global Multiplex Assays Market Outlook, By Multiplex Real-Time PCR (2021-2030) ($MN)
  • Table 20 Global Multiplex Assays Market Outlook, By Fluorescence Detection (2021-2030) ($MN)
  • Table 21 Global Multiplex Assays Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 22 Global Multiplex Assays Market Outlook, By Application (2021-2030) ($MN)
  • Table 23 Global Multiplex Assays Market Outlook, By Research & Development (2021-2030) ($MN)
  • Table 24 Global Multiplex Assays Market Outlook, By Biomarker Discovery & Validation (2021-2030) ($MN)
  • Table 25 Global Multiplex Assays Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 26 Global Multiplex Assays Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
  • Table 27 Global Multiplex Assays Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 28 Global Multiplex Assays Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
  • Table 29 Global Multiplex Assays Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 30 Global Multiplex Assays Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
  • Table 31 Global Multiplex Assays Market Outlook, By Metabolism & Endocrinology Disorders (2021-2030) ($MN)
  • Table 32 Global Multiplex Assays Market Outlook, By Nervous System Disorders (2021-2030) ($MN)
  • Table 33 Global Multiplex Assays Market Outlook, By Other Clinical Diagnostics (2021-2030) ($MN)
  • Table 34 Global Multiplex Assays Market Outlook, By End User (2021-2030) ($MN)
  • Table 35 Global Multiplex Assays Market Outlook, By Hospitals & Diagnostic Laboratories (2021-2030) ($MN)
  • Table 36 Global Multiplex Assays Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 37 Global Multiplex Assays Market Outlook, By Academic Institutes (2021-2030) ($MN)
  • Table 38 Global Multiplex Assays Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.